What is MaxCyte's net investment in lease?

MaxCyte (MXCT) reported net investment in lease of $10.7M in Q1 2026.

How has MaxCyte's net investment in lease changed year-over-year?

MaxCyte's net investment in lease decreased by 7.3% year-over-year, from $11.54M to $10.7M.

What is the long-term trend for MaxCyte's net investment in lease?

Over 5 years (2020 to 2025), MaxCyte's net investment in lease has grown at a 44.6% compound annual growth rate (CAGR), from $1.73M to $10.92M.

MaxCyte MXCT Net Investment in Lease

Net Investment in Lease at other companies

Bio-Rad LaboratoriesBIO

——

Ginkgo BioworksDNA

——

Immix Biopharma, Inc.IMMX

——

Rapid Micro BiosystemsRPID

——

PDE

Pro-Dex, Inc.PDEX

——

RepligenRGEN

——

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's net investment in lease?: MaxCyte (MXCT) reported net investment in lease of $10.7M in Q1 2026.
How has MaxCyte's net investment in lease changed year-over-year?: MaxCyte's net investment in lease decreased by 7.3% year-over-year, from $11.54M to $10.7M.
What is the long-term trend for MaxCyte's net investment in lease?: Over 5 years (2020 to 2025), MaxCyte's net investment in lease has grown at a 44.6% compound annual growth rate (CAGR), from $1.73M to $10.92M.